These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 3318704

  • 1. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
    Shitara N, Nakamura H, Genka S, Takakura K.
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Current status of interferon therapy on malignant brain tumor].
    Nagai M, Arai T, Kohno S, Iizuka E.
    Gan No Rinsho; 1983 May; 29(6):608-15. PubMed ID: 6876429
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Adoptive immunotherapy in patients with medulloblastoma by LAK cells].
    Shimizu K, Tamura K, Yamada M, Okamoto Y, Miyao Y, Park K, Matsui Y, Hayakawa T, Takimoto H, Mogami H.
    No To Shinkei; 1989 Oct; 41(10):991-5. PubMed ID: 2605046
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y, Konishi T, Suzui H, Kamijo Y, Kang Y, Okumura T, Kaneko T, Kikuchi H.
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct 20; 24(10):2411-7. PubMed ID: 2614179
    [Abstract] [Full Text] [Related]

  • 7. Autologous natural killer cell therapy for human recurrent malignant glioma.
    Ishikawa E, Tsuboi K, Saijo K, Harada H, Takano S, Nose T, Ohno T.
    Anticancer Res; 2004 Oct 20; 24(3b):1861-71. PubMed ID: 15274367
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.
    Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA.
    Cancer Res; 1986 Apr 20; 46(4 Pt 2):2101-4. PubMed ID: 3512079
    [Abstract] [Full Text] [Related]

  • 9. [Effect of interferon on malignant brain tumor].
    Wakabayashi T, Yoshida J, Kobayashi T, Kageyama N, Kanzaki M.
    Gan To Kagaku Ryoho; 1982 Aug 20; 9(8):1400-6. PubMed ID: 7184455
    [Abstract] [Full Text] [Related]

  • 10. Local application of interferon to malignant brain tumors.
    Nagai M, Arai T, Kohno S, Kohase M.
    Tex Rep Biol Med; 1982 Aug 20; 41():693-8. PubMed ID: 7052705
    [No Abstract] [Full Text] [Related]

  • 11. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep 20; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

  • 12. [Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors].
    Yoshida J, Wakabayashi T, Kato K, Enomoto H, Kito A, Kageyama N.
    Gan To Kagaku Ryoho; 1986 Mar 20; 13(3 Pt 1):520-4. PubMed ID: 3456740
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical effect of human fibroblast interferon (BM532) on malignant brain tumors--with special reference to gliomas].
    Nagai M.
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar 20; 24(3):638-46. PubMed ID: 2671205
    [Abstract] [Full Text] [Related]

  • 16. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP, Lichtor T, Lin H, Tarlock K, Cohen EP.
    J Neurosurg; 2006 Jul 20; 105(1 Suppl):65-70. PubMed ID: 16871873
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
    Kimoto Y, Taguchi T.
    Biken J; 1987 Jun 20; 30(2):29-38. PubMed ID: 3501954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.